Filing Flows

Filing Flows › Tenon Medical (TNON) › Q3 2025

Tenon Medical (TNON) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 13, 2025

Tenon Medical (TNON) reported revenue of $1.2M for the third quarter 2025 (Q3 2025), +32% from a year earlier and +108% from the quarter before. Operating margin was -289.2%, net loss $3.3M (284.7% of revenue).

Revenue$1.2M
Year over year+32%
Quarter over quarter+108%
Operating margin-289.2%
Net earnings−$3.3M

Tenon Medical, Q3 2025: revenue $1.2M (+32% year over year), operating margin -289.2%, net loss $3.3M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$1.2M+108%+32%
Operating profit−$3.4M——
Net earnings−$3.3M——
Operating cash flow−$3.8M——

What changed

Revenue was $1.2M in Q3 2025, up 32% year over year and up 108% from the previous quarter.

Gross margin was 65.9%, up 18.8 points from a year earlier. Operating costs exceeded revenue by $3.4M, an operating margin of -289.2%. Operating expenses grew 15% against revenue growth of 32%. The fastest-growing cost line was Sales & marketing (+27%). The quarter ended with a net loss of $3.3M, wider than the previous quarter's $2.8M loss.

Operating cash flow was −$3.8M. Non-cash charges added back $77K of depreciation and amortization and $58K of share-based compensation. Working capital and other items used $620K. Capital expenditures of −$111K exceeded it, leaving free cash flow of −$3.7M.

Questions

What was Tenon Medical's revenue in the third quarter 2025?

Tenon Medical (TNON) reported revenue of $1.2M for the third quarter 2025 (Q3 2025), +32% from a year earlier and +108% from the quarter before.

Was Tenon Medical profitable in the third quarter 2025?

Operating loss was $3.4M (-289.2% of revenue) and net loss $3.3M.

Open the interactive Sankey →

Source: Tenon Medical 10-Q on SEC EDGAR.